Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
AnimalPharm
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Deals
|
M&A
|
Financials
|
Strategy
|
Lifecycle Management
|
Legal
|
Merck indicates launch/pricing plans for Victrelis in Europe
26 July 2011
Sukaina Virji
sukaina.virji@informa.com
Please Login to read the full article.
Not a subscriber?
Subscribe to Scrip
Request a FREE Trial
RELATED CONTENT
NEWS
Scrip News
Achillion raising $56.6 million to advance hepatitis C candidates
Gilenya and Tasigna drive new product growth at Novartis
EMA recommends 4SC's resminostat for orphan designation
Big pharma abandoning HIV discounts in middle-income countries, MSF claims
Other Informa News
US FDA draft proposals for companion diagnostics signals simultaneous drug/IVD review
Brazil courts Iraq’s “valuable unexplored medtech market”
COMMENT
Scrip Comment
The Great Disappearotech: shrinking before your very eyes
About Us
Getting Started
Subscribe
Free Trial
Advertise
Awards
White Papers
Executive Briefing
Classifieds
Recruitment
JOB OF THE WEEK
Promote your vacancy here
SCRIP's ONLINE DIRECTORY
Classified ads